VEGF Background Information The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast growth factors (FGFs), platelet derived growth factor (PDGF) and vascular endothelial growth factor (VEGF). VEGF is a dimeric glycoprotein with structural homology to PDGF. Several variants of VEGF have been described that arise by alternative mRNA splicing. It has been speculated that VEGF may function as a tumor angiogenesis factor in vivo because the expression pattern of VEGF is consistent with a role in embryonic angiogenesis. VEGF mRNA is formed in some primary tumors, VEGF is produced by tumor cell lines in vitro and VEGF mitogenic activity appears to be restricted to endothelial cells. A member of the PDGF receptor family, Flt, has been identified as a high-affinity receptor for VEGF.
VEGF (C-1) Product Citations
See how others have used VEGF (C-1): sc-7269 antibody and or VEGF (C-1) antibody conjugates.
99 total citations
Loading citations.
VEGF (C-1)
Click on image to enlarge
VEGF (C-1): sc-7269. Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue (A) and immunofluorescence staining of methanol-fixed Ramos cells (B) showing cytoplasmic localization.
VEGF (C-1): sc-7269. Western blot analysis of human recombinant VEGF.
